GenVec, Inc. (GNVC) said it appointed Cynthia Collins as president and chief executive officer, or CEO, effective May 23, 2012. Besides, Collins is expected to be appointed to the Board of Directors of GenVec.
Effective upon Collins' appointment, Paul Fischer will step down as GenVec's president and CEO and as a member of the Board.
Collins formerly served as Group vice president, Cellular Analysis Business of Beckman Coulter from 2007 to until its sale in 2011. Before joining Beckman Coulter, she served as CEO of Sequoia Pharmaceuticals, Inc., a private biotechnology company developing antiviral drugs. Before that, she served as president of Clinical Micro Sensors, Inc., a wholly owned subsidiary of Motorola where she directed the development and commercialization of molecular diagnostic microarray products and led the eventual strategic divestiture of the division.
by RTT Staff Writer
For comments and feedback: email@example.com